X-47239175-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001371072.1(USP11):c.282T>C(p.Phe94Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00105 in 1,205,197 control chromosomes in the GnomAD database, including 7 homozygotes. There are 350 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 6 hom., 185 hem., cov: 23)
Exomes 𝑓: 0.00059 ( 1 hom. 165 hem. )
Consequence
USP11
NM_001371072.1 synonymous
NM_001371072.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.357
Genes affected
USP11 (HGNC:12609): (ubiquitin specific peptidase 11) Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. This gene encodes a deubiquitinating enzyme which lies in a gene cluster on chromosome Xp11.23 [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant X-47239175-T-C is Benign according to our data. Variant chrX-47239175-T-C is described in ClinVar as [Benign]. Clinvar id is 788053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.357 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00551 (617/112011) while in subpopulation AFR AF= 0.0177 (546/30836). AF 95% confidence interval is 0.0165. There are 6 homozygotes in gnomad4. There are 185 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USP11 | NM_001371072.1 | c.282T>C | p.Phe94Phe | synonymous_variant | Exon 2 of 21 | ENST00000377107.7 | NP_001358001.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00548 AC: 614AN: 111956Hom.: 6 Cov.: 23 AF XY: 0.00539 AC XY: 184AN XY: 34106
GnomAD3 genomes
AF:
AC:
614
AN:
111956
Hom.:
Cov.:
23
AF XY:
AC XY:
184
AN XY:
34106
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00157 AC: 269AN: 171051Hom.: 2 AF XY: 0.00103 AC XY: 59AN XY: 57259
GnomAD3 exomes
AF:
AC:
269
AN:
171051
Hom.:
AF XY:
AC XY:
59
AN XY:
57259
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000595 AC: 650AN: 1093186Hom.: 1 Cov.: 30 AF XY: 0.000460 AC XY: 165AN XY: 358962
GnomAD4 exome
AF:
AC:
650
AN:
1093186
Hom.:
Cov.:
30
AF XY:
AC XY:
165
AN XY:
358962
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00551 AC: 617AN: 112011Hom.: 6 Cov.: 23 AF XY: 0.00541 AC XY: 185AN XY: 34171
GnomAD4 genome
AF:
AC:
617
AN:
112011
Hom.:
Cov.:
23
AF XY:
AC XY:
185
AN XY:
34171
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at